Immune Therapy Holdings (Sweden)
Immune Therapy Holdings AB or ITH is a Swedish biotechnology R&D holding company headquartered at the Karolinska Institutet and Karolinska University Hospital in Stockholm. ITH's research is primarily focused on its Tailored Leukapheresis treatment for immune mediated inflammatory diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Immune Therapy Holdings (Sweden), Sweden, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
79%
Total
Publications
63
Total Open
Publications
50
Total
Citations
744
Open Access
Percentage
79%
Total
Publications
63
Total Open
Publications
50
Total
Citations
744
Breakdown
Publisher Open
30%
Both
46%
Other Platform Open
3%
Closed
21%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 33%
15
Hybrid 35%
16
No Guarantees 32%
15
Other Platform Open
Domain 83%
25
Institution 53%
16
Other Internet 3%
1
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 25 |
Konstfack University of Arts, Crafts, and Design - Publications | Institution | 8 |
University of Szeged - SZTE Publicatio Repozitórium | Institution | 2 |
University of Geneva - Archive ouverte UNIGE | Institution | 2 |
Imperial College London - Spiral | Institution | 2 |
Goethe University Frankfurt - Publication Server of Goethe University Frankfurt am Main | Institution | 2 |
University of Oslo - Duo Research Archive | Institution | 1 |
University of Melbourne - Minerva Access | Institution | 1 |
University of Liège - Open Repository and Bibliography | Institution | 1 |
University of Leicester - Leicester Research Archive | Institution | 1 |